Clinical Trials Logo

Clinical Trial Summary

GlaxoSmithKline will be conducting this trial to compare analgesic efficacy of paracetamol 1000 mg vs 650 mg. The post-surgical dental pain model will be used to evaluate the analgesic efficacy of paracetamol. Each subject will be enrolled in the study for up to six weeks. The duration of the entire study will be approximately 18 weeks. Each subject will have to come to the clinic for three visits (Screening, Treatment and Follow up visits).


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01075243
Study type Interventional
Source GlaxoSmithKline
Contact
Status Completed
Phase Phase 4
Start date November 2009
Completion date March 2010

See also
  Status Clinical Trial Phase
Terminated NCT01512160 - Efficacy Of Pf-04531083 In Treating Post-Surgical Dental Pain Phase 2
Completed NCT01082081 - Post-operative Dental Pain Study Comparing Analgesic Efficacy Phase 4